Exchange: NASDAQ·Updated 04:13 AM EDT
PBLS logo

PBLS Parabilis Medicines Inc.

$39.40
$0.29
(0.74%)
Pre-Market
Prev Close $39.11
Reported EarningsAug 13
Mkt Cap$4.83B
Vol1,274.00

About PBLS

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
69

Bullish Sentiment

How do you feel about PBLS?

Advertisement|Remove ads.